FVCBankcorp Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

FVCBankcorp şirketinin toplam varlıkları $2.3B ve toplam özkaynağı $230.8M dır. Toplam mevduat $2.0B ve toplam krediler $1.9B dır. 2.5% Net Faiz Marjı kazanır. Şu anda toplam kredilerin 0.2% i olan kötü krediler için yeterli ödeneği vardır. Nakit ve kısa vadeli yatırımlar $179.4M dir.

Anahtar bilgiler

9.9x

Varlık/özkaynak oranı

2.5%

Net faiz marjı

Toplam mevduat	US$1.96b
Kredi/mevduat oranı	Uygun
Batık krediler	0.2%
Sorunlu krediler için ayrılan karşılık	Yeterli
Cari oran	Düşük
Nakit ve eşdeğerleri	US$179.37m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

FVCBankcorp Non-GAAP EPS of $0.48 beats by $0.01, revenue of $18.1M beats by $0.6M

Oct 20

FVCBankcorp Non-GAAP EPS of $0.43 beats by $0.01, revenue of $17.44M beats by $2.04M

Jul 21

With EPS Growth And More, FVCBankcorp (NASDAQ:FVCB) Is Interesting

Jun 08

We Think Some Shareholders May Hesitate To Increase FVCBankcorp, Inc.'s (NASDAQ:FVCB) CEO Compensation

May 13

What You Need To Know About FVCBankcorp, Inc.'s (NASDAQ:FVCB) Investor Composition

Mar 13

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: FVCB 'nin Varlık/Özsermaye oranı ( 9.9 x) düşüktür.

Kötü Krediler İçin Ödenek: FVCB yeterli kötü krediler için bir ödeneği var ( 536 %).

Düşük Riskli Yükümlülükler: FVCB 'un yükümlülüklerinin 95% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: FVCB Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 81% ).

Düşük Riskli Mevduatlar: FVCB 'nin Kredi/Mevduat oranı ( 95% ) uygundur.

Kötü Kredilerin Seviyesi: FVCB uygun düzeyde kötü krediler içeriyor ( 0.2 %).

FVCBankcorp Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

CEO & Chairman notifies of intention to sell stock

Independent Director recently sold US$51k worth of stock

Independent Director exercised options and sold US$57k worth of stock

Investor sentiment deteriorates as stock falls 17%

CEO & Chairman recently sold US$51k worth of stock

CEO & Chairman notifies of intention to sell stock

New major risk - Revenue and earnings growth

Investor sentiment improves as stock rises 18%

Price target decreased by 7.4% to US$12.50

Executive VP & COO exercised options to buy US$323k worth of stock.

Independent Director exercised options to buy US$249k worth of stock.

Independent Director recently sold US$137k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$114k worth of stock

Independent Director notifies of intention to sell stock

Consensus EPS estimates fall by 21%

Investor sentiment deteriorates as stock falls 16%

FVCBankcorp, Inc., Annual General Meeting, May 15, 2024

Chairman & CEO recently sold US$118k worth of stock

Independent Director exercised options and sold US$95k worth of stock

Independent Director exercised options and sold US$65k worth of stock

Executive VP & Chief Lending Officer exercised options and sold US$97k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$370k worth of stock

Insufficient new directors

Executive VP & Chief Lending Officer recently sold US$72k worth of stock

Consensus EPS estimates fall by 34%

FVCBankcorp, Inc. Announces Executive Changes

Chairman & CEO recently sold US$83k worth of stock

New minor risk - Profit margin trend

Independent Director recently sold US$100k worth of stock

Investor sentiment deteriorates as stock falls 16%

Independent Director recently sold US$90k worth of stock

FVCBankcorp, Inc. Reports Net Charge-Offs for the Second Quarter Ended June 30, 2023

FVCBankcorp, Inc. Announces Resignation of Thomas L Patterson, Director

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 16%

Executive VP & CFO recently bought US$60k worth of stock

Consensus revenue estimates fall by 11%

Price target decreased by 12% to US$12.75

Full year 2022 earnings: EPS and revenues miss analyst expectations

Now 27% undervalued after recent price drop

Independent Director recently sold US$183k worth of stock

Independent Director recently sold US$100k worth of stock

Consensus EPS estimates fall by 11%

Price target decreased by 12% to US$19.38

FVCBankcorp, Inc. Reports Unaudited Net Charge-Offs for the Fourth Quarter Ended December 31, 2022

Now 22% undervalued after recent price drop

Full year 2022 earnings: EPS and revenues miss analyst expectations

Independent Director notifies of intention to sell stock

President exercised options and sold US$72k worth of stock

FVCbank Taps Bruce Gemmill as Senior Vice President / Chief Marketing Officer

Independent Director recently sold US$99k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$102k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$103k worth of stock

Third quarter 2022 earnings: EPS exceeds analyst expectations

FVCBankcorp Non-GAAP EPS of $0.48 beats by $0.01, revenue of $18.1M beats by $0.6M

FVCBankcorp, Inc. and FVCbank Appoints Marc N. Duber to Board of Directors

Now 20% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

FVCBankcorp Non-GAAP EPS of $0.43 beats by $0.01, revenue of $17.44M beats by $2.04M

Price target decreased to US$22.17

Independent Director recently sold US$323k worth of stock

First quarter 2022 earnings: EPS misses analyst expectations

Insufficient new directors

First quarter 2022 earnings: EPS misses analyst expectations

Insufficient new directors

Fvcbankcorp, Inc. Announces That Morton A. Bender, A Director of the Company, Passed Away on April 11, 2022

FVCBankcorp, Inc., Annual General Meeting, May 18, 2022

Blue Ridge Bankshares, Inc. (NYSEAM:BRBS) cancelled the acquisition of FVCBankcorp, Inc. (NASDAQ:FVCB) in a merger of equals.

Now 21% undervalued after recent price drop

Independent Director exercised options to buy US$371k worth of stock.

Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.29 in 3Q 2020)